跳至主要内容
临床试验/NCT05209321
NCT05209321已完成不适用

Predictors of Malnutrition in Patients With Haematological Cancer

Jens Rikardt Andersen1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
62
试验地点
1
主要终点
Loss of Lean Body Mass

研究概览

简要总结

The primary purpose of this study is to conduct an exploratory study of which predictors are most significant for LBM loss in patients with lymphoma. Patients are measured by weight and bio impedance and furthermore, their physical activity, nutritional status, diet and quality of life during the course are estimated. This is done in order to determine any changes in the aforementioned factors during the course of the cancer treatment that may have a bearing on the loss of LBM.

详细描述

It was assessed by the National Ethics Committee that the experiment was not subject to notification, cf. section 14 (1) of the Committee Act. 2. The project has been approved by the Ethical Research Committee for SUND and SCIENCE, University of Copenhagen.. The project was also approved by the Danish Data Protection Agency at Region Zealand with case no .: REG-166-2020. A data processor agreement was established between Region Zealand and thesis students.

Data is presented as mean +/- SD. Continuous data are analyzed using Pearson correlation analysis presented by correlation coefficient r and a p-value. Pearson correlation analysis is used to measure the strength of the linear relationship between normally distributed variables. A significance level of 5% is used.

Binary values are assigned for data assessing secondary endpoints. Subsequently, a multiple linear regression analysis is performed to examine the influence of discrete variables on the primary endpoint.

For statistical analysis and design of plots, the programs, R Studio (version 1.4.1106) and Excel (version 16.43) is used.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with haematological cancer
  • Patients receiving myelosuppressive chemotherapy for haematological disease
  • Adult patients

排除标准

  • Patients who cannot understand and speak Danish or English
  • Pregnant and breastfeeding
  • Patients who suffer from dementia

结局指标

主要结局

Loss of Lean Body Mass

时间窗: 2 months

Lean Body Mass measured by bioimpedance

次要结局

未报告次要终点

研究者

发起方
Jens Rikardt Andersen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jens Rikardt Andersen

Assoc Prof

University of Copenhagen

研究点 (1)

Loading locations...

相似试验